A series of substituted pyrazino[2,3‐f][1,10]‐phenanthroline (Rppl) ligands (with R=Me, COOH, COOMe) were synthetized (see 1–4 in Scheme 1). The ligands can be visualized as formed by a bipyridine and a quinoxaline fragment (see A and B). Homoleptic [Ru(R1ppl)3](PF6)2 and heteropleptic [Ru(R1ppl){(R2)2bpy}2](PF6)2 (R1=H, Me, COOMe and R2=H, Me) metal complexes 5–7 and 8–13, respectively, based on these ligands were also synthesized and characterized by conventional techniques (Schemes 2 and 3, resp.). In the heteroleptic complexes, the R1‐ppl ligand reduces at a less‐negative potential than the bpy ligand, reflecting the acceptor property conferred by the quinoxaline moiety. The potentiality of some of these complexes as solar‐cell dyes is discussed.
No takes yet. Share an insight, caveat, or question.
Delgadillo et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: